We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Culture Dish Helps Human Embryonic Stem Cell Research

By LabMedica International staff writers
Posted on 08 Jul 2010
A new synthetic Petri dish coating could overcome a major hurdle to the advancement of human embryonic stem cell research.

Under current regulations, current stem cell lines have limitations in yielding human therapies because the cells have been grown on animal-based substances that do not behave in expected ways. More...
"These nondefined, animal-based components create issues with the FDA [U.S. Food and Drug Administration] and hinder clinical applications,” said Dr. Joerg Lahann, associate professor of chemical engineering at the University of Michigan (U-M; Ann Arbor, USA).

Dr. Lahann and Dr. Gary Smith, an associate professor in obstetrics and gynecology in the U-M Health System, and their coworkers constructed a new stem cell growth matrix that is completely synthetic and does not contaminate the stem cells with foreign substances that could interfere with their normal function. An article on the research was published online, on June 2010 in the journal Nature Biotechnology.

Today's most typically used matrices are mouse embryonic fibroblast cells and Matrigel, which is made from mouse tumors. "The problem is that the mouse-derived cells have batch-to-batch variability, and they secrete factors that nobody really understands. Stem cells are very sensitive to their environment,” Dr. Lahann said.

The unknown factors hamper researchers' attempts to pinpoint how and under what conditions stem cells differentiate--questions paramount to the development of future stem cell therapies.

The team evaluated six different polymer coatings and found that a water-soluble gel with the acronym PMEDSAH performed well when attached to the Petri dish even after 25 rounds of harvesting stem cells to grow new colonies. "We have designed a fully synthetic, fully chemically defined hydrogel that has long-term stability and no batch-to-batch variability,” Dr. Smith noted. "Moreover, we have established that it can be used for long-term growth of human embryonic stem cells while maintaining all of their known normal functions. These include normal genetic makeup, lack of spontaneous differentiation, and maintenance of pluripotency, which means they can still become any cell type of the human body. This is a perfect example of an interdisciplinary collaboration leading to information gained and future discovery of cures and improvements of human health.”

Related Links:

University of Michigan



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.